Stokes Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Sell
35,871
-32,379
-47% -$2.83M 0.7% 51
2026
Q1
$5.82M Sell
68,250
-10,500
-13% -$936K 1.3% 35
2025
Q4
$6.22M Sell
78,750
-357
-0.5% -$28K 1.42% 35
2025
Q3
$6.32M Buy
79,107
+11,553
+17% +$986K 1.47% 33
2025
Q2
$6.14M Sell
67,554
-1,395
-2% -$127K 1.5% 32
2025
Q1
$6.46M Buy
68,949
+2,516
+4% +$225K 1.64% 31
2024
Q4
$6.04M Sell
66,433
-3,364
-5% -$321K 1.56% 30
2024
Q3
$7.25M Sell
69,797
-4,613
-6% -$470K 1.86% 26
2024
Q2
$7.22M Sell
74,410
-1,550
-2% -$143K 2.01% 21
2024
Q1
$6.84M Sell
75,960
-170
-0.2% -$14.4K 1.99% 24
2023
Q4
$6.07M Buy
76,130
+200
+0.3% +$15K 1.92% 28
2023
Q3
$5.4M Buy
75,930
+1,623
+2% +$121K 1.88% 26
2023
Q2
$5.72M Buy
74,307
+18,154
+32% +$1.41M 1.93% 25
2023
Q1
$4.22M Buy
56,153
+18,243
+48% +$1.36M 1.43% 37
2022
Q4
$2.99M Sell
37,910
-19,310
-34% -$1.45M 1.03% 48
2022
Q3
$4.02M Buy
+57,220
New +$4.49M 1.5% 36
2021
Q1
Sell
-26,782
Closed -$2.29M 69
2020
Q4
$2.29M Buy
26,782
+850
+3% +$70.3K 1% 44
2020
Q3
$2M Buy
25,932
+4,402
+20% +$336K 0.96% 44
2020
Q2
$1.58M Buy
21,530
+20
+0.1% +$1.42K 0.83% 46
2020
Q1
$1.43M Sell
21,510
-115
-0.5% -$8.11K 0.86% 47
2019
Q4
$1.49M Buy
21,625
+830
+4% +$56.6K 0.75% 53
2019
Q3
$1.53M Sell
20,795
-70
-0.3% -$5.08K 0.83% 52
2019
Q2
$1.5M Buy
20,865
+385
+2% +$27.3K 0.85% 52
2019
Q1
$1.4M Buy
20,480
+1,590
+8% +$103K 0.85% 52
2018
Q4
$1.12M Sell
18,890
-5,105
-21% -$319K 0.78% 52
2018
Q3
$1.61M Buy
23,995
+1,870
+8% +$125K 0.98% 49
2018
Q2
$1.43M Buy
22,125
+880
+4% +$57.6K 0.94% 52
2018
Q1
$1.52M Buy
21,245
+4,100
+24% +$295K 1% 52
2017
Q4
$1.29M Buy
+17,145
New +$1.25M 0.87% 51

Other funds holding CL

Stokes Capital Advisors's CL Position: Q2 2026 in Review

Stokes Capital Advisors reduced its Colgate-Palmolive (CL) stake by 47% in Q2 2026, selling an estimated $2.83M and leaving 35,871 shares worth $3.29M. The position accounts for 0.7% of the portfolio, ranked #51.

Stokes Capital Advisors first reported a position in CL in Q4 2017 and has held it in 29 quarters since. The position peaked at $7.25M in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Stokes Capital Advisors held 35,871 shares of Colgate-Palmolive worth $3.29M as of Q2 2026.
  • Stokes Capital Advisors sold 32,379 Colgate-Palmolive shares in Q2 2026, an estimated $2.83M.
  • Colgate-Palmolive made up 0.7% of Stokes Capital Advisors's portfolio in Q2 2026, its #51 holding.
  • Stokes Capital Advisors first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 29 quarters since.
  • Stokes Capital Advisors's Colgate-Palmolive position peaked at $7.25M in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.